Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain - PubMed (original) (raw)
Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain
Abiodun A Ogunjimi et al. Mol Cell. 2005.
Free article
Abstract
The conjugation of ubiquitin to proteins involves a cascade of activating (E1), conjugating (E2), and ubiquitin-ligating (E3) type enzymes that commonly signal protein destruction. In TGFbeta signaling the inhibitory protein Smad7 recruits Smurf2, an E3 of the C2-WW-HECT domain class, to the TGFbeta receptor complex to facilitate receptor degradation. Here, we demonstrate that the amino-terminal domain (NTD) of Smad7 stimulates Smurf activity by recruiting the E2, UbcH7, to the HECT domain. A 2.1 A resolution X-ray crystal structure of the Smurf2 HECT domain reveals that it has a suboptimal E2 binding pocket that could be optimized by mutagenesis to generate a HECT domain that functions independently of Smad7 and potently inhibits TGFbeta signaling. Thus, E2 enzyme recognition by an E3 HECT enzyme is not constitutively competent and provides a point of control for regulating the ubiquitin ligase activity through the action of auxiliary proteins.
Similar articles
- Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain.
Wiesner S, Ogunjimi AA, Wang HR, Rotin D, Sicheri F, Wrana JL, Forman-Kay JD. Wiesner S, et al. Cell. 2007 Aug 24;130(4):651-62. doi: 10.1016/j.cell.2007.06.050. Cell. 2007. PMID: 17719543 - Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation.
Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Wrana JL. Kavsak P, et al. Mol Cell. 2000 Dec;6(6):1365-75. doi: 10.1016/s1097-2765(00)00134-9. Mol Cell. 2000. PMID: 11163210 - Structural Diversity of Ubiquitin E3 Ligase.
Toma-Fukai S, Shimizu T. Toma-Fukai S, et al. Molecules. 2021 Nov 4;26(21):6682. doi: 10.3390/molecules26216682. Molecules. 2021. PMID: 34771091 Free PMC article. Review. - Ubiquitin-conjugating enzyme E2C: a potential cancer biomarker.
Xie C, Powell C, Yao M, Wu J, Dong Q. Xie C, et al. Int J Biochem Cell Biol. 2014 Feb;47:113-7. doi: 10.1016/j.biocel.2013.11.023. Epub 2013 Dec 17. Int J Biochem Cell Biol. 2014. PMID: 24361302 Review.
Cited by
- The role of WWP1 and WWP2 in bone/cartilage development and diseases.
Wang Y, Wu Z, Wang C, Wu N, Wang C, Hu S, Shi J. Wang Y, et al. Mol Cell Biochem. 2024 Nov;479(11):2907-2919. doi: 10.1007/s11010-023-04917-7. Epub 2024 Jan 22. Mol Cell Biochem. 2024. PMID: 38252355 Review. - Structural and functional validation of a highly specific Smurf2 inhibitor.
Tessier TM, Chowdhury A, Stekel Z, Fux J, Sartori MA, Teyra J, Jarvik N, Chung J, Kurinov I, Sicheri F, Sidhu SS, Singer AU, Zhang W. Tessier TM, et al. Protein Sci. 2024 Feb;33(2):e4885. doi: 10.1002/pro.4885. Protein Sci. 2024. PMID: 38147466 Free PMC article. - SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition.
Lai X, Lui SKL, Lam HY, Adachi Y, Sim WJ, Vasilevski N, Armstrong NJ, Bridgeman SC, Main NM, Tan TZ, Tirnitz-Parker JEE, Thiery JP, Ebi H, Kumar AP, Eichhorn PJA. Lai X, et al. NPJ Precis Oncol. 2023 Dec 15;7(1):136. doi: 10.1038/s41698-023-00486-6. NPJ Precis Oncol. 2023. PMID: 38102334 Free PMC article. - Structure of the human UBR5 E3 ubiquitin ligase.
Wang F, He Q, Zhan W, Yu Z, Finkin-Groner E, Ma X, Lin G, Li H. Wang F, et al. Structure. 2023 May 4;31(5):541-552.e4. doi: 10.1016/j.str.2023.03.010. Epub 2023 Apr 10. Structure. 2023. PMID: 37040767 Free PMC article. - Roles of TGF‑β signalling pathway‑related lncRNAs in cancer (Review).
Hu Z, Liu Y, Liu M, Zhang Y, Wang C. Hu Z, et al. Oncol Lett. 2023 Feb 2;25(3):107. doi: 10.3892/ol.2023.13693. eCollection 2023 Mar. Oncol Lett. 2023. PMID: 36817052 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous